trava tirzepatide pricing Dosing Tirzepatide Flex-Dose 2 mL Injectable

If side effects are intolerable at any dose, the standard approach is to reduce back to the last tolerated dose and remain there for an additional four weeks before attempting escalation again

Tirzepatide (Mounjaro, Zepbound) is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management

Since the half-life is about 5 days, complete clearance requires roughly 5 to 7 half-lives

This guide clarifies FDA-approved expiration guidelines for each GLP-1 medication, proper storage practices, and what happens if you use medication beyond recommended timeframes

Rapid weight loss, which is common with high-efficacy GLP-1 agonists, can exacerbate this ratio